Xenoport Inc (XNPT.OQ)

XNPT.OQ on NASDAQ Stock Exchange Global Select Market

5.41USD
10:52am EDT
Price Change (% chg)

$0.02 (+0.37%)
Prev Close
$5.39
Open
$5.42
Day's High
$5.54
Day's Low
$5.39
Volume
13,143
Avg. Vol
151,071
52-wk High
$12.98
52-wk Low
$4.62

XNPT.OQ

Chart for XNPT.OQ

About

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally for the treatment of neurological disorders. The product candidates are prodrugs that are created by modifying the chemical structure of marketed drugs, referred to as parent drugs, and are designed to correct... (more)

Overall

Beta: 0.51
Market Cap (Mil.): $255.50
Shares Outstanding (Mil.): 47.40
Dividend: --
Yield (%): --

Financials

  XNPT.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -1.02 -- --
ROI: -43.79 -2.58 18.76
ROE: -51.01 -2.66 19.59
Search Stocks

XenoPort to drop multiple sclerosis drug, shares fall

- XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo.

20 May 2013

UPDATE 2-XenoPort to drop multiple sclerosis drug after trial failure

* Drug does not show statistical significance compared with placebo

20 May 2013

XenoPort to drop multiple sclerosis drug after trial failure

May 20 - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.

20 May 2013

Competitors

  Price Change
GlaxoSmithKline plc (GSK.L) 1,706.50p +22.50
Depomed Inc (DEPO.OQ) $6.53 +0.01
Pfizer Inc. (PFE.N) $29.18 -0.05
Novartis AG (NOVN.VX) CHF66.60 +0.35
UCB SA (UCB.BR) €43.99 +0.67
NeurogesX, Inc (NGSX.PK) $0.01 +0.00
Impax Laboratories Inc (IPXL.OQ) $21.00 +0.26
Allergan, Inc. (AGN.N) $91.71 +0.59
Sun Pharma Advanced Research Company (SPRC.NS) Rs119.45 -5.35
Solvay S.A. (SOLB.BR) €104.10 +2.30

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$472.00
Provider: Pechala's Reports
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks